5 Best Biotech Stocks to Invest In

2. Travere Therapeutics, Inc. (TVTX)

A biopharmaceutical company Travere Therapeutics, Inc. (NASDAQ: TVTX) first initiated a position in the first quarter of this year. It is the second-largest stock holding of billionaire biotech hedge fund, accounting for 5.67% of the overall portfolio. The hedge fund’s investment in biopharmaceutical company looks profitable considering a share price gain of 80% in the last twelve months.

“Eric Dube, Ph.D., chief executive officer of Retrophin said: “The DUPLEX Study of sparsentan in FSGS is nearing completion of enrollment and the PROTECT Study in IgA nephropathy achieved enrollment of the 280th patient during the quarter, positioning us for topline readouts from the proteinuria endpoints in both pivotal studies next year.”

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)